Clinical Trial Update: A Study to Evaluate Quality of Life in Patients Switched to Solifenacin From Other Antimuscarinics

View source ↗

Summary

The completed study evaluated quality of life in patients switched from other antimuscarinics to solifenacin for overactive bladder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Solifenacin (solifenacin)

Snippet

Sponsor: Astellas Pharma Europe B.V. | Conditions: Urinary Bladder, Overactive | Status: COMPLETED